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) production by human gingival fibroblasts. In this study, we examined the herbs constituting kakkonto that exhibit this
effect. Shokyo strongly and concentration dependently and kanzo and keihi moderately decreased LPS-induced PGE
2
production.




), annexin 1 andCOX-2 expression, and
LPS-induced extracellular signal-regulated kinase (ERK) phosphorylation. Kanzo inhibited COX-2 activity but increased annexin 1
and COX-2 expression and did not alter LPS-induced ERK phosphorylation. Keihi inhibited COX-2 activity and LPS-induced ERK
phosphorylation but slightly increased COX-2 expression and did not alter cPLA
2
and annexin 1 expression. These results suggest
that the mechanism of shokyo is through the inhibition of cPLA
2
activity, and that of kanzo and keihi is through the inhibition of
COX-2 activity and indirect inhibition of cPLA
2
activity. Therefore, it is possible that shokyo and kakkonto are clinically useful for
the improvement of inflammatory responses.
1. Introduction
Periodontal disease is accompanied by inflammation of the
gingiva and destruction of periodontal tissues, leading to





), interleukin-6 (IL-6), and IL-8 are known to
play important roles in inflammatory responses and tissue
degradation. PGE
2
has several functions in vasodilation,
enhancement of vascular permeability and pain, and induc-
tion of osteoclastogenesis and is believed to play important
roles in inflammatory responses and alveolar bone resorption
in periodontal disease [1].
A kampo medicine, kakkonto (TJ-1), has been clinically
used for various diseases such as common cold, coryza,
initial stage of febrile diseases, and inflammatory diseases.
There are several reports showing that kakkonto possesses
antiallergic [2, 3] and antiviral [4–7] effects in animal and
in vitro experimental models. Regarding anti-inflammatory
effects, kakkonto has been reported to decrease PGE
2
produc-
tion in cultured rabbit astrocytes [8]. Recently, we reported
that kakkonto suppresses lipopolysaccharide- (LPS-) induced
PGE
2
production by human gingival fibroblasts (HGFs) [9],
as well as shosaikoto [10], hangeshashinto [11], and orento
[12].
Kakkonto is constituted with seven herbs (kakkon, taiso,
mao, kanzo, keihi, shakuyaku, and shokyo). Some herbs such
as keihi and shokyo are known to possess anti-inflammatory
effects and are clinically used to treat inflammatory diseases
[13, 14]. However, which compositions in kakkonto primarily
show this effect is unclear. In this study, to elucidate the effect
of kakkonto on decreasing LPS-induced PGE
2
production
more precisely, we examined those herbs that constitute
kakkonto and their mechanisms.
2. Materials and Methods
2.1. Reagents. The ingredients of kakkonto formula are shown
in Table 1. Kakkonto was purchased from Tsumura & Co.
Powders of six herbs (taiso, mao, kanzo, keihi, shakuyaku,
Hindawi Publishing Corporation
International Scholarly Research Notices
Volume 2016, Article ID 9351787, 9 pages
http://dx.doi.org/10.1155/2016/9351787
2 International Scholarly Research Notices
Table 1: The ingredient of kakkonto formula.
Japanese name Latin name Amount (g) Amount (g/gof product)∗
Kakkon Puerariae Radix 4.0 0.111
Taiso Zizyphi fructus 3.0 0.083
Mao Ephedrae Herba 3.0 0.083
Kanzo Glycyrrhizae Radix 2.0 0.056
Keihi Cinnamomi Cortex 2.0 0.056
Shyakuyaku Paeoniae Radix 2.0 0.056
Shokyo Zingiberis Rhizoma 2.0 0.056
Total 18.0 0.500
∗7.5 g of kakkonto product contains 3.75 g of a dried extract of the mixed
crude drugs.
and shokyo) were provided by Tsumura&Co. (Tokyo, Japan).
Kakkon (Puerariae Radix) was purchased from Tsumura &
Co. A hot water extract of kakkon was prepared as reported
previously [15]. In brief, 10 g of kakkon was decocted for 1 h
with 100mL of water. The decoctions were mixed, concen-
trated, and lyophilized. The w/w yield of kakkon was 2.1%.
Powders of herbs and kakkontowere suspended inDulbecco’s
modified Eagle’s medium (D-MEM, Sigma, St. Louis, MO)
containing 10% heat-inactivated fetal calf serum, 100U/mL
penicillin, and 100mg/mL streptomycin (culture medium)
and were stored at 4∘C overnight under shaking. Then,
the suspension was centrifuged and the supernatant was
filtrated through a 0.45𝜇mpore membrane. Lipopolysaccha-
ride (LPS) from Porphyromonas gingivalis 381 was provided
by Professor Nobuhiro Hanada (School of Dental Medicine,





), NS-398 (cyclooxygenase-2 (COX-2) inhibitor),















-) specific inhibitor) were purchased from
Cayman Chemical (Ann Arbor, MI). Other reagents were
purchased from Nacalai Tesque (Kyoto, Japan).
2.2. Cells. HGFs were prepared as described previously [11].
In brief, HGFs were prepared from free gingiva during the
extraction of an impacted tooth, with the informed consent
of the subjects who consulted Matsumoto Dental University
Hospital. The free gingival tissues were cut into pieces and
seeded onto 24-well plates (AGC Techno Glass Co., Chiba,
Japan). HGFs weremaintained in the culturemedium at 37∘C
in a humidified atmosphere of 5% CO
2
. For passage, HGFs
were trypsinized, suspended, and plated into new cultures in
a 1 : 3 dilution ratio. HGFs were used between the 10th and
15th passages in the assays. This study was approved by the
Ethical Committee ofMatsumotoDental University (number
0063).
2.3. Measurement of Cell Viability. The numbers of cells were
measured using WST-8 (Cell Counting Kit-8; Dojindo,
Kumamoto, Japan) according to the manufacturer’s instruc-
tions. In brief, the media were removed by aspiration and
the cells were treated with 100 𝜇L of mixture of WST-8 with
culture medium for 2 h at 37∘C in CO
2
incubator. Optical
density was measured (measured wavelength at 450 nm and
reference wavelength at 655 nm) using an iMark microplate
reader (Bio-Rad, Hercules, CA), and the mean background
value was subtracted from each value.
2.4. Measurement of PGE2. HGFs were seeded in 96-well
plates (10,000 cells/well) and incubated in serum-containing
medium at 37∘C overnight. Then, the cells were treated with
various concentrations of each herb or kakkonto in the
absence or presence of LPS (10 ng/mL) for 24 h (200𝜇L each
well) in triplicate or quadruplicate for each sample. After
collecting the culture supernatants, viable cell numbers were
measured using WST-8 as described above.
The concentrations of PGE
2
in the culture supernatants
were measured by enzyme-linked immunosorbent assay
(ELISA), according to the manufacturer’s instructions (Cay-
man Chemical), and were adjusted by the number of viable
cells. Data are represented as pg per 10,000 cells (mean ± SD).
2.5. Measurement of COX-2 and Prostaglandin E Synthase.
COX-2 and prostaglandin E (PGE) synthase activities were
evaluated as shown previously [16] with slight modifications.
In brief, to estimate COX-2 activity, HGFs were treated with
LPS and herb for 8 h, washed, and incubated in culture
medium containing exogenous arachidonic acid (10𝜇M).The
concentrations of PGE
2
in the supernatants were measured
by ELISA. PGE synthase activity was determined after a
15min incubation with exogenous PGH
2
(10 nM), and the
concentrations of PGE
2
were measured. Data are represented
as pg per 10,000 cells (mean ± SD).
2.6. Preparation of Cell Lysates. HGFs were cultured in
60mmdishes and treated with combinations of LPS and herb
for the indicated times. Then, cells were washed twice with
Tris-buffered saline, transferred into microcentrifuge tubes,
and centrifuged at 6,000×g for 5min at 4∘C. Supernatants
were aspirated and the cells were lysed on ice in lysis buffer
(50mM Tris-HCl, pH 7.4, 1% Nonidet P-40, 0.25% sodium
deoxycholate, 150mM NaCl, 1mM ethylene glycol bis(2-
aminoethyl ether)tetraacetic acid (EGTA), 1mM sodium
orthovanadate, 10mM sodium fluoride, 1mMphenylmethyl-
sulfonyl fluoride, 10 𝜇g/mL aprotinin, 5𝜇g/mL leupeptin, and
1 𝜇g/mL pepstatin) for 30min at 4∘C. Then, the samples
were centrifuged at 12,000×g for 15min at 4∘C, and the
supernatants were collected. The protein concentration was
measured using a BCA Protein Assay Reagent kit (Pierce
Chemical Co., Rockford, IL).
2.7. Western Blotting. The samples (10 𝜇g of protein) were
fractionated in a polyacrylamide gel under reducing con-
ditions and transferred onto a polyvinylidene difluoride
(PVDF) membrane (Hybond-P; GE Healthcare, Uppsala,
Sweden). The membranes were blocked with 5% ovalbu-
min for 1 h at room temperature and incubated with pri-
mary antibody for an additional 1 h. The membranes were
further incubated with horseradish peroxidase-conjugated
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secondary antibodies for 1 h at room temperature. Protein
bands were visualized with an ECL kit (GE Healthcare).
Antibodies against COX-2 (sc-1745, 1 : 500 dilution),
cPLA
2
(sc-438, 1 : 200 dilution), annexin 1 (sc-11387, 1 : 1,000
dilution), and actin (sc-1616, 1 : 1,000 dilution), which detects
a broad range of actin isoforms, were purchased from Santa
Cruz Biotechnology (Santa Cruz, CA). Antibodies against
extracellular signal-regulated kinase (ERK; p44/42 MAP
kinase antibody, 1 : 1,000 dilution) and phosphorylated ERK
(Phospho-p44/42MAPK (Thr202/Tyr204) (E10)monoclonal
antibody, 1 : 2,000 dilution) were purchased from Cell Sig-
naling Technology (Danvers, MA). Horseradish peroxidase-
conjugated anti-goat IgG (sc-2020, 1 : 20,000 dilution) was
procured from Santa Cruz, and anti-rabbit IgG (1 : 20,000
dilution) and anti-mouse IgG (1 : 20,000 dilution) were pur-
chased from DakoCytomation (Glostrup, Denmark).
2.8. Statistical Analysis. Differences between groups were
evaluated using the two-tailed pairwise comparison test
with a pooled variance, followed by correction with Holm’s
method (total of 10 null hypotheses; 3 null hypotheseswithout
herb versus with herb in the absence of LPS, 3 null hypotheses
without herb versus with herb in the presence of LPS, and 4
null hypotheses without LPS versus with LPS) (Figure 1). Dif-
ferences between the control group and experimental groups
were evaluated using two-tailed Dunnett’s test (Figures 3 and
4).
All computations were performedwith the statistical pro-
gram R (http://www.r-project.org/). Dunnett’s test was per-
formed using the “glht” function in the “multcomp” package.
Values with 𝑃 < 0.05 were considered significantly different.
3. Results
3.1. Effect of Herbs on PGE2 Production. We examined
whether the herbs affect LPS-induced PGE
2
production by
HGFs. The concentrations of PGE
2
were adjusted according
to viable cell number. When HGFs cells were treated with
10 ng/mL of LPS, HGFs cells produced large amounts of
PGE
2
. Shokyo strongly and significantly decreased LPS-
induced PGE
2
production in a concentration-dependent
manner (Figure 1). Kanzo and keihi moderately decreased
LPS-induced PGE
2
production (Figure 1). Taiso and mao
had no effect on LPS-induced PGE
2
production. Kakkon
and shakuyaku increased LPS-induced PGE
2
production
(Figure 1). In the absence of LPS, kakkon increased PGE
2
production, but kanzo decreased PGE
2
production (Figure 1).
Other herbs had no or little effect on PGE
2
production.
Therefore, we used three herbs (kanzo, keihi, and shokyo) in
the following experiments.
Next, we examined the synergistic effect of three herbs
(shokyo, kanzo, and keihi) on PGE
2
production and com-
pared it with that of kakkonto. The concentrations of each
herb (56𝜇g/mL) were determined based on the ingredient
of kakkonto formula (Table 1). The mixture of herbs further
decreased PGE
2
production. The combination of two herbs
(shokyo + keihi and shokyo + kanzo) decreased PGE
2
production to a similar level with 1mg/mL of kakkonto.
Moreover, the mixture of three herbs decreased PGE
2
pro-
duction more than kakkonto (Figure 2).
3.2. PLA2 Isoform Activities in HGFs. PLA2 is the most
upstream enzyme in the arachidonic acid cascade and
releases arachidonic acid from the plasma membrane.
PLA
2














), and others [13]. To elucidatewhich type of
PLA
2
(s) contribute to arachidonic acid production in HGFs,





CAY10502 significantly decreased LPS-induced PGE
2
pro-
duction by approximately half (Figure 3). However, both
iPLA
2
-specific inhibitor BEL and sPLA
2
-specific inhibitor
thioetheramide-PC did not alter LPS-induced PGE
2
produc-





s in the following experiments.
3.3. Effect of Herbs on COX-2 and PGE Synthase Activities.
Then, we examined the mechanism by which kanzo, keihi,
and shokyo decreased LPS-induced PGE
2
production more
directly. In order to bypass PLA
2
, we added exogenous
arachidonic acid. Kanzo and keihi significantly decreased
LPS-induced PGE
2
production to approximately half, while
shokyo slightly but not significantly increased PGE
2
produc-




The formation of PGE
2
from arachidonic acid requires
both COX and PGE synthase. To examine the effect of





. However, all herbs had no effect on PGE
2
formation from exogenous PGH
2
(Figure 4(b)).
3.4. Effects of Herbs on Molecular Expression in the Arachi-
donic Acid Cascade. We examined whether herbs affect the
expression of molecules in the arachidonic acid cascade.
Kanzo increased cPLA
2
expression, while keihi and shokyo
showed no effect (Figure 6). Based on its molecular weight
(approximately 90 kDa in human) [17, 18], this cPLA
2
is
believed to be cPLA
2
𝛼 subtype.
Annexin 1, also named as lipocortin, is an anti-inflam-
matory mediator produced by glucocorticoids and inhibits
cPLA
2
activity [19, 20]. Kanzo increased annexin 1 expression,
while keihi and shokyo showed no effect (Figure 6).
COX-2 was not detected in the absence of LPS and
LPS-induced COX-2 expression in HGFs. Kanzo and keihi
increased LPS-induced COX-2 expression. However, shokyo
did not alter LPS-induced COX-2 expression (Figure 5).
3.5. Effects of Herbs on ERK Phosphorylation. cPLA
2
is
reported to be directly phosphorylated at Ser505 by phos-
phorylated ERK, resulting in cPLA
2
activation [21, 22].
Therefore, we examinedwhether herbs suppress LPS-induced
ERK phosphorylation. Keihi suppressed LPS-induced ERK
phosphorylation at 30min, while kanzo and shokyo did not
(Figure 6).


























































































































































































Figure 1: Effects of herbs on the production of PGE
2
. HGFs were treated with combinations of LPS (0 and 10 ng/mL) and herb (0, 10, 30, and
100𝜇g/mL) for 24 h. Concentrations of PGE
2
were measured by ELISA, adjusted by cell number, and expressed as pg per 10,000 cells (mean
± SD, 𝑛 = 3). Open circles, treatment without LPS; closed circles, treatment with 10 ng/mL of LPS. ∗𝑃 < 0.05, ∗∗𝑃 < 0.01, and ∗∗∗𝑃 < 0.001
(without herb versus with herb). #𝑃 < 0.05, ##𝑃 < 0.01, and ###𝑃 < 0.001 (without LPS versus with LPS). 𝑃 values were calculated by pairwise
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Figure 2: Effects of mixture of keihi, kanzo, and shokyo on the
production of PGE
2
. HGFs were treated with combinations of LPS
(10 ng/mL) and herbs (56 𝜇g/mL) or kakkonto (1mg/mL) for 24 h.
Concentrations of PGE
2
were measured by ELISA, adjusted by cell
number, and expressed as pg per 10,000 cells (mean ± SD, 𝑛 = 4).
4. Discussion
In the present study, we examined the effect of herbs consti-
tuting kakkonto on LPS-induced PGE
2
production by HGFs.
Shokyo, kanzo, and keihi decreased LPS-induced PGE
2
pro-
duction in a concentration-dependent manner. In particular,
shokyo showed the most marked effect. Previously, we exam-
ined themechanisms of kakkonto [9] and shosaikoto [10] that
contain shokyo and demonstrated that shosaikoto inhibited






















Figure 3: The contribution of PLA
2
isoforms in HGFs. HGFs were
treated with LPS (10 ng/mL) and PLA
2
inhibitor for 24 h. Con-
centrations of PGE
2
were measured by ELISA, adjusted by cell
number, and expressed as pg per 10,000 cells (mean ± SD, 𝑛 = 4).
CAY10502, cPLA
2
𝛼 inhibitor (100 nM); BEL (bromoenol lactone),
iPLA
2
inhibitor (20𝜇M); Thio-PC (thioetheramide-PC), sPLA
2
inhibitor (20𝜇M); and ZR (shokyo, 100𝜇g/mL) a positive control.
kakkonto suppressed ERK phosphorylation. Based on our
findings in the present study, shokyo is believed to play an
important role in decreasing LPS-induced PGE
2
production
by HGFs in kakkonto and shosaikoto. In addition, the mix-
ture of three herbs (shokyo, kanzo, and keihi) synergistically
6 International Scholarly Research Notices
















































Figure 4: Effects of herbs onCOX and PGE synthase activities. HGFs were treated with LPS (10 ng/mL) and herb (100𝜇g/mL) for 8 h, washed,
and then treated with (a) 10𝜇M arachidonic acid or (b) 10 nM PGH
2
for (a) 30min or (b) 15min. Concentrations of PGE
2
were measured by
ELISA, adjusted by cell number, and expressed as pg per 10,000 cells (mean ± SD, 𝑛 = 3). 𝑃 values by Dunnett’s test are indicated. GR, kanzo;








Figure 5: Effects of herbs on cPLA
2
, annexin 1, and COX-2 expres-
sions. HGFs were treated with a combination of LPS (10 ng/mL)
and herb (100𝜇g/mL) for 8 h, and protein levels were examined by
Western blotting. GR, kanzo; CC, keihi; and ZR, shokyo.
decreased PGE
2
production (Figure 2). The effect of two
herbs mixture including shokyo was comparable to that of
kakkonto. Moreover, the effect of the three herbs mixture was
stronger than that of kakkonto because mao and shakuyaku,
which increase LPS-induced PGE
2
productions (Figure 1),
are not included. These results suggest that the combination
of these herbs in kakkonto is sufficient to decrease PGE
2
production.
Shokyo (Zingiberis Rhizoma) is the powdered rhizome
of ginger (Zingiber officinale Roscoe). Several reports have






Figure 6: Effects of herbs on LPS-induced ERK phosphorylation.
HGFs were untreated (0 h), treated with LPS (10 ng/mL), or treated
with both LPS and herb (100𝜇g/mL) for 30min. Western blotting
was performed using antiphosphorylated ERKor anti-ERK antibod-
ies. pERK, phosphorylated ERK. Upper band indicates ERK1 (p44
MAPK) and lower band ERK2 (p42 MAPK). GR, kanzo; CC, keihi;
and ZR, shokyo.
animal models, and in vitro models. Ginger has been widely
used in diet and also as a treatment for rheumatoid arthritis,
fever, emesis, nausea, and migraine headache [14]. Recently,
a systematic review and meta-analysis reported that the
extracts of Zingiberaceae including turmeric, ginger, Javanese
ginger, and galangal are clinically effective as hypoanalgesic
agents [23]. In an animal model, the aqueous extract of
ginger significantly decreased serum PGE
2
level by oral or
intraperitoneal administration by the rat [24]. Moreover,
crude hydroalcoholic extract of ginger reduced the serum
level of PGE
2
and improved tracheal hyperreactivity and lung
inflammation induced by LPS in rat [25]. Ethanol extract
of ginger reduced the tissue level of PGE
2
and improved
acetic acid-induced ulcerative colitis in the rat [26]. In in
vitro model, gingerols and shogaols extracted from ginger
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are reported to decrease PGE
2
production by several mech-
anisms. 10-Gingerol, 8, 10-shogaol [27], and 8-shogaol and
8-paradol [28] inhibit COX-2 activity. Moreover, gingerols,
but not 6-shogaol, suppress COX-2 expression in LPS-treated
human leukemic monocyte lymphoma U937 cells [29].
Our data showed that shokyo did not suppress COX-2
expression and that shokyo did not alter PGE
2
production
when arachidonic acid or PGH
2
is added to bypass their
upstream pathway. These data suggest that shokyo did not
affect the downstream pathway of arachidonic acid, which
includes COX-2 and PGE synthase. Therefore, shokyo is
considered to inhibit PLA
2
, which is the upstream pathway of
arachidonic acid. PLA
2
hydrolyses the sn-2 ester bond of glyc-
erophospholipids. Although PLA
2











is the primary isoform in HGFs (Figure 3).
Our data showed that shokyo only slightly decreased cPLA
2
expression but did not alter annexin 1 expression, which
suppresses PLA
2
activity. Therefore, shokyo may primarily
inhibit cPLA
2
activity. Although we have no direct data to
show that shokyo inhibits cPLA
2
activity, this assumption






















first identified and characterized by Ca2+-dependence and
substrate preference for arachidonoyl phospholipids [32].
We detected cPLA
2
at approximately 90 kDa as well as
in human platelets and erythrocytes [17, 18], although the
molecular weight of cPLA
2
𝛼 protein on the basis of amino
acid sequence is 85 kDa. Therefore, cPLA
2
that we detected
in HGFs is believed to be cPLA
2
𝛼. In contrast, cPLA
2
𝛼-
specific inhibitor CAY10502 decreased LPS-induced PGE
2
production to approximately half (Figure 3), suggesting that
other cPLA
2





to producing arachidonic acid, and shokyo may inhibit these
cPLA
2
s. However, we could not detect cPLA
2
𝛽 (114 kDa in
humans), cPLA
2
𝛾 (61 kDa in humans), cPLA
2
𝜖 (100 kDa in
murine), and cPLA
2
𝜁 (96 kDa in murine) [13]. Although
the molecular weight of cPLA
2
𝛿 from human/murine is 92-
93 kDa [13], cPLA
2
𝛿 is distributed in the placenta [31]. These
results suggest that there is no or very little contribution of
cPLA
2
s other than cPLA
2
𝛼 inHGFs; therefore, the remaining
mechanisms remain to be elucidated.
As described above, our data that shokyo did not alter
COX-2 activity and COX-2 expression are different from
those of gingerols and shogaols. Although there is no obvious
evidence, the reason may be the preparation method of
shokyo.Gingerols and shogaols are extremely hydrophobic by
their structures. Indeed, these compositions were extracted
from hydrophobic phase in previous studies. However, the
powders of herbs used in this study are prepared by decoc-
tion; therefore, hydrophilic compositions are likely to be
extracted but hydrophobic compositions are unlikely to be
extracted.
Kanzo (Glycyrrhizae Radix) is the powdered root or
stolon of Glycyrrhiza uralensis Fischer. Kanzo is also known
to have anti-inflammatory effects [33]. We demonstrated that
kanzo decreased LPS-induced PGE
2
production (Figure 1)
and further demonstrated that kanzo increased annexin 1
expression (Figure 5), regardless of the increase of cPLA
2
expression, suggesting that kanzo decreases LPS-induced
PGE
2
production by enhancement of annexin 1 expression
and following inhibition of cPLA
2
activity.However, the com-
positions that increase annexin 1 expression have not been
reported. Moreover, we demonstrated that kanzo increased
LPS-induced COX-2 expression (Figure 5). These findings
are similar to those obtained using kampo medicines orento




acid is added, while kanzo did not decrease when PGH
2
was
added (Figure 4). These results suggest that kanzo inhibits
COX-2 activity but not PGE synthase. Indeed, kanzo inhibits
COX-2 activity [35]. Therefore, kanzo inhibits arachidonic
acid cascade in multiple points and cPLA
2
and COX-2
activities. However, because the contribution of kanzo in
kakkonto may be little, the ability of kanzo to decrease LPS-
induced PGE
2
production is weak. Kanzo contains the com-
positions such as glycyrrhizin, glycyrrhizic acid, liquiritin,
and isoliquiritigenin. Nonetheless, the contributions of these
compositions are unlikely in this study because they sup-
pressed LPS-induced COX-2 expression [36–39]. Moreover,
the compositions that inhibit COX-2 activity have not been
reported. Therefore, other compositions may contribute to
our findings.
Keihi (Cinnamomi Cortex) is the powdered bark of
Cinnamomum cassia. Cinnamon has been widely used for
the treatment of fever and inflammation [13]. Cinnamon
improves nephritis, purulent dermatitis, and hypertension
and enhances wound healing. Cinnamon extracts have been
used for the improvement of or protection against com-
mon cold, diarrhea, and pain [13]. In a previous study, we
demonstrated that ERK phosphorylation was suppressed by
kakkonto [23] and orento [12], which also contains keihi.
In this study, we demonstrated that this effect is responsible
for keihi (Figure 6). Moreover, we demonstrated that keihi
increased LPS-induced COX-2 expression (Figure 5) and
that keihi decreased LPS-induced PGE
2
production when
arachidonic acid is added while keihi did not decrease when
PGH
2
was added. These results suggest that keihi inhibits
COX-2 activity but not PGE synthase. Therefore, keihi
inhibits arachidonic acid cascade in multiple points, cPLA
2
activation, and COX-2 activity. However, the contribution of
keihi in kakkonto may be little because the ability of keihi to
decrease LPS-induced PGE
2
production is weak. Keihi con-
tains the compositions such as cinnamic aldehyde, cinnamic
alcohol, cinnamic acid, and coumarin. Cinnamic aldehyde,
but not others, suppressed LPS-induced COX-2 expression
and decreased PGE
2
production by RAW264.7 cells [40,
41]. Moreover, cinnamic aldehyde suppressed carrageenan-
induced COX-2 expression and improved footpad edema in
mouse [40]. However, the contribution of cinnamic aldehyde
is unlikely in this study.
Aspirin-induced asthma (AIA) occurs after ingestion of
acid nonsteroidal anti-inflammatory drugs (NSAIDs) such
as aspirin and indomethacin [42, 43]. It is believed that
AIA is caused by leukotorienes (LTs), in which contract
8 International Scholarly Research Notices
bronchus are increased by acid NSAIDs [42, 43]. Similarly,
acid NSAIDs are known to exacerbate a usual asthma. In
this study, we speculate that shokyo inhibits cPLA
2
activity.
Therefore, the production of LTs is believed to be decreased
because shokyo blocks arachidonic acid cascade at cPLA
2
level. In this case, shokyo may be safely used for patients
with asthma, including AIA, instead of conventional anti-
inflammatory drugs. Moreover, oral administration of ginger
protects against aspirin-induced gastric ulcers in rats [44].
Therefore, shokyo is possible to be available as an anti-
inflammatory drug instead of NSAIDs.
5. Conclusion
We demonstrated that shokyo strongly and kanzo and keihi
moderately decreased LPS-induced PGE
2
production. More-
over, shokyo may inhibit cPLA
2
activity and kanzo and keihi
inhibit COX-2 activity directly and cPLA
2
activity indirectly.
These results suggest that shokyo, and kakkonto, is clinically
useful for the improvement of inflammatory responses in
periodontal disease and other diseases.
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